Dr. Reddy’s Laboratories Ltd (REDY)

4,139.50
-43.35(-1.04%)
  • वॉल्यूम:
    6,497
  • बोली/पुछे:
    0.00/0.00
  • दिन की रेंज:
    4,130.00 - 4,213.60

REDY समीक्षा

पिछला बंद
4,182.85
दिन की रेंज
4,130-4,213.6
आय
212.86B
खुला
4,182.4
52 सप्ताह रेंज
3,655-5,078.8
ईपीएस
179.2
वॉल्यूम
6,497
मार्केट कैप
687.19B
लाभांश (यील्ड)
30.00
(0.72%)
औसत वॉल्यूम (3एम)
20,067
पी/ई अनुपात
23.23
बीटा
0.228
1- वर्ष बदलाव
-13.63%
बकाया शेयर
166,006,864
अगली कमाई तिथि
27 अक्तू॰ 2022
डॉ रेड्डीज पर आपकी भावना क्या है?
या
अभी बाज़ार बंद हैं। वोटिंग बाजार का समय के दौरान खुली है।

डॉ रेड्डीज लेबोरेटरीज समाचार

डॉ रेड्डीज लेबोरेटरीज विश्लेषण

डॉ रेड्डीज लेबोरेटरीज कंपनी प्रोफाइल

डॉ रेड्डीज लेबोरेटरीज कंपनी प्रोफाइल

कर्मचारी
22739
बाज़ार
भारत
  • प्रकार:इक्विटी
  • बाज़ार:भारत
  • आईसआईन:INE089A01023
  • एस/न:DRREDDY

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company’s Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. Its Proprietary Products segment focuses on the research and development of differentiated formulations. The Others segment engages in developing therapies in the fields of oncology and inflammation. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

और पढ़ें

तकनीकी सारांश

प्रकार
5 मिनट
15 मिनट
प्रति घंटा
दैनिक
मासिक
मूविंग एवरेजमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयतटस्थ
तकनीकी संकेतकमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रय
सारांशमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयबेचना
  • how much p/e of a company and i invest money?
    0
    • how much p/e of a company and i invest money?
      0
      • dr reddyy 5500 cross kar jayega agle 15 din me wait n watch
        1
        • to Kya aap isme tred le rahe hai
          0
      • dr reddyy 5500 cross kar jayega agle 15 din me wait n watch
        0
        • sir dr reddy 4600 tak bhi nhi ja pa rha kya wajah hai esme रैली nhi aye hai
          0
          • stock are v Buli Renj SL4800 TO Rest.5230
            0
            • 5350 kal
              0
              • 5350
                0
                • 5200
                  0
                  • 5000 kal
                    0